New Article Shows Hemoglobin Depletion Technology for the Sub-Proteome
Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching the red cell sub-proteome, from human red blood cells. In brief, using proteomics-based evaluation of red blood cells (RBC), the authors identified differentially abundant proteins associated with Obstructive Sleep Apnea Syndrome (OSA).
Proteome variations between various time points were assessed. The article states “RBC cytoplasmic fraction depleted of hemoglobin, using Hemovoid™ system, were analyzed by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE), the 2D image software-based analyzed and relevant differentially abundant proteins identified by mass spectrometry (MS)”. The authors conclude that 31 protein spots were differentially abundant, corresponding to 21 unique proteins possibly due to the existence of posttranslational modifications.
“This article illustrates the importance of removing hemoglobin in order to perform proteomic analysis of red cells. The ability to enrich for the underlying sub-proteome which would normally mask many proteins from red cells is a unique feature of HemoVoid™. Many differentially regulated proteins were identified, demonstrating its usefulness in proteomic investigations” states Swapan Roy, Ph.D., President and Founder of Biotech Support Group.
Feliciano, A., Vaz, F., Valentim-Coelho, C., Torres, V. M., Silva, R., Prosinecki, V., Penque, D. (2017). Evening and morning alterations in obstructive sleep Apnea red blood cell proteome. Data in Brief, 11, 103–110. doi:10.1016/j.dib.2017.01.005
This article has been republished from materials provided by Biotech Support Group. Note: material may have been edited for length and content. For further information, please contact the cited source.
Ataxin Links Long Term-Memory and NeurodegenerationNews
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018